Mon, June 25, 2012
[ Mon, Jun 25th 2012 ] - Market Wire
Myths or Factsa" Campaign
Sun, June 24, 2012
Sat, June 23, 2012
Fri, June 22, 2012
Thu, June 21, 2012
Wed, June 20, 2012
Tue, June 19, 2012
Mon, June 18, 2012
Sun, June 17, 2012
Sat, June 16, 2012
Fri, June 15, 2012
Thu, June 14, 2012
Wed, June 13, 2012
Tue, June 12, 2012
Mon, June 11, 2012
Sat, June 9, 2012
Fri, June 8, 2012
Thu, June 7, 2012
Wed, June 6, 2012

Codexis Announces Inducement Option Award and Restricted Stock Award to John J. Nicols


//health-fitness.news-articles.net/content/2012/ .. and-restricted-stock-award-to-john-j-nicols.html
Published in Health and Fitness on Wednesday, June 13th 2012 at 13:31 GMT by Market Wire   Print publication without navigation


REDWOOD CITY, Calif.--([ ])--Codexis, Inc. (NASDAQ:CDXS), a developer of industrial enzymes to enable the cost-advantaged production of biofuels, bio-based chemicals and pharmaceutical intermediates, today announced that it has granted a stock option award and restricted stock award to John J. Nicols, Codexisa newly appointed President and Chief Executive Officer. These inducement awards were approved by the Compensation Committee of the Codexis Board of Directors on June 12, 2012, effective as of June 13, 2012, and granted as an inducement material to Mr. Nicolsa entering into employment with Codexis in accordance with NASDAQ Listing Rule 5635(c)(4).

Codexis granted Mr. Nicols an option to purchase 400,000 shares of Codexisa common stock with an exercise price equal to $3.46 per share, the closing price per share of common stock as reported by NASDAQ on June 13, 2012. The option will vest on June 13, 2013 as to 25 percent of the shares subject thereto, with the remaining shares vesting ratably on a monthly basis over a period of 36 months thereafter, subject to Mr. Nicolsa continuous service with Codexis through the applicable vesting date, such that the option would be fully vested and exercisable on June 13, 2016. In addition, Codexis granted to Mr. Nicols an award of 750,000 shares of restricted stock that will vest as to 25 percent of the shares subject thereto on each anniversary of June 13, 2012, subject to Mr. Nicolsa continuous service to Codexis through the applicable vesting date, such that the restricted stock ward will be fully vested on June 13, 2016, subject to accelerated vesting in accordance with Mr. Nicolsa employment agreement.

Codexis is providing this information in accordance with NASDAQ Listing Rule 5635(c)(4).

About Codexis, Inc.

Codexis, Inc. is a developer of industrial enzymes to enable the cost-advantaged production of biofuels, bio-based chemicals and pharmaceutical intermediates. Codexis' product lines include CodeXymea" Cellulase Enzymes and CodeXola" Detergent Alcohol. Partners and customers include global leaders such as Shell, Merck and Pfizer. For more information, see [ www.codexis.com ].


Publication Contributing Sources